OptMyCare, a clinically engineered AI platform in healthcare & risk management, announced today that it raised $3 million in Series A financing from a robust group of investors led by LiveOak Ventures of Austin, Texas. This infusion of additional capital will enable OptMyCare™ to accelerate its customer acquisition plans, continuously refine its technology, onboard key management personnel, and add experienced healthcare & technology leaders.

医疗保健和风险管理领域的临床工程人工智能平台OptMyCare今天宣布，它从德克萨斯州奥斯汀的LiveOak Ventures领导的一群强大的投资者那里筹集了300万美元的a系列融资。这一额外资金的注入将使OptMyCare能够加速其客户收购计划，不断改进其技术，配备关键管理人员，并增加经验丰富的医疗保健和技术领导者。

Total investment to date is $4.5 million.Founded in 2019 by Dr. Antony E. Pfaffle, MD, and Dr. Saravanan Balamuthusamy, MD, MPH, FASN, FASDIN, OptMyCare™ brings a uniquely clinical perspective to the engineering of health risk solutions. Dr. Pfaffle has twenty years of experience in stop-loss and risk management consulting and has founded or co-founded multiple healthcare companies.

迄今为止，总投资为450万美元。由医学博士AntonyE.Pfaffle博士和医学博士SaravananBalamuthusamy博士（医学博士、公共卫生硕士、FASN、FASDIN、OptMyCare）于2019年成立，为健康风险解决方案的工程设计带来了独特的临床视角。Pfaffle博士在止损和风险管理咨询方面拥有20年的经验，并创建或共同创建了多家医疗保健公司。

Dr. Balamuthusamy cofounded a large multispecialty physician group in North Texas and brings in two decades of academic clinical experience in developing a comprehensive health risk management solution. Working with a team of healthcare, tech, and insurance experts, Dr. Pfaffle and Dr. Balamuthusamy aim to revolutionize the field of risk management, utilizing technologically unique precision analytics to change the way that companies navigate risk..

Balamuthusamy博士在德克萨斯州北部共同成立了一个大型多专业医师小组，并在开发全面的健康风险管理解决方案方面积累了二十年的学术临床经验。Pfaffle博士和Balamuthusamy博士与医疗保健、技术和保险专家团队合作，旨在彻底改变风险管理领域，利用技术独特的精确分析来改变公司应对风险的方式。。